Glaucoma Research Foundation

Glaucoma Research Foundation

Shaffer Grants

50,000 $

For more than 40 years, Glaucoma Research Foundation has been the premiere organization in glaucoma research funding.

We support new high-impact clinical, epidemiological and laboratory research based on our strategic research goals.

Strategic Research Goals

  • Protect and restore the optic nerve
  • Accurately detect glaucoma and monitor its progress
  • Find the genes responsible for glaucoma
  • Understand the intraocular pressure system and develop better treatments
  • Determine the risk factors for glaucoma damage using systematic outcomes data

Core Values

  • Involve people with glaucoma in the design, implementation and evaluation of programs.
  • Encourage collaboration among experts in many fields of study to achieve GRF goals.
  • Communicate research goals and results to the scientific community and the public.
  • Ensure that new glaucoma treatments maintain or improve individuals’ quality of life.
  • Encourage innovative clinical trial studies and laboratory research.
  • Develop cell and animal models of glaucoma to support research studies.
  • Facilitate and support the development of physician-scientists to advance glaucoma research.

The online application is accepted annually from June 1 until July 15 

251 Post Street, Suite 600
San Francisco, CA 94108
(415) 986-3162
(800) 826-6693
Bisherige Preisträger:


Benjamin J. Frankfort, MD, PhD, Baylor College of Medicine, für sein Projekt: „Adrenergic Receptor Function and Role in Neuroprotection“
Karsten Gronert, PhD an der University of California, Berkeley, für sein Projekt: „LXB4 Regulation of Microglia Homeostatic Function a Neuroprotective Target“
Wendy Liu, MD, PhD, an der Stanford University, für ihr Projekt: „Investigating Mechanosensitive Ion Channel Variants and their Role in Glaucoma“
Xiaorong Liu, PhD, University of Virginia, für ihr Projekt: „An In Vivo Biomarker to Monitor Glaucoma Progression“
Cezary Rydz, MD, an der University of California, Irvine, für sein Projekt: „Modulating Ocular Hypertension Induced Accelerated Aging in Rodent Retina“
James Tribble, PhD, am Karolinska Institutet in Stockholm, Schweden, für das Projekt: „Drug-driven Identification of Inflammatory Pathways in Retinal Microglia“
James Walsh, MD, PhD, Washington University in St. Louis, für sein Projekt: „Choroid Resident T Cells are Vital for Retinal Ganglion Cell Neuroprotection in Ocular Hypertensive Injury“
Benjamin Xu, MD, PhD , an der University of Southern California, für das Projekt: „In Vivo Ultrasound Elastography of Iris Stiffness in Angle Closure Glaucoma.“



Steven Bassnett, PhD; Washington University School of Medicine
Project: Role of LOXL1 Propeptide Aggregation in Pseudoexfoliation Glaucoma

Stewart Bloomfield, PhD; State University of New York College of Optometry
Project: Retinal Gap Junctions Form Novel Targets for Neuroprotective Therapy in Glaucoma

Alex Huang, MD, PhD; Doheny Eye Institute
Project: Investigating Subconjuctival Lymphatics for the Treatment of Glaucoma and Eye Disorders

Tatjana Jakobs, MD; Schepens Eye Research Institute
Project: The Transcription Factor Runx1 as a Novel Mediator of Astrocyte Reactivity in the Optic Nerve

Rachel Kuchtey, MD, PhD; Vanderbilt Eye Institute
Project: Investigation of Ocular Biomechanical Defects in Mice with Microfibril and Elastic Fiber Defects

Herbert Lachmann, MD; Albert Einstein College of Medicine
Project: Gene Expression Profiling in Trabecular Meshwork Cells derived from Induced Pluripotent Stem Cells made from Patients with Lowe Syndrome, a Genetic Disorder that causes Cataracts and Glaucoma

Matthew B. Veldman, PhD; Medical College of Wisconsin
Project: Zebrafish Retinal Ganglion Cell Survival in the Context of Pro-Apoptotic Bax Signaling

Trent A. Watkins, PhD; Baylor College of Medicine
Project: Highly Parallel Assessment of RGC Regenerative and Neuroprotective Targets




Steven Barnes, PhD; Project: Functional Resilience of Retinal Ganglion Cells During Mitochondrial Dysfunction

Adnan Dibas, PhD; Project: Endothelin Converting Enzyme Knockdown is Neuroprotective in Glaucomatous Neuropathy

Ankur Jain, PhD; Project: Autophagy-targeted Treatment for Myocilin-associated Glaucoma

Pierre Mattar, MSc, PhD; Project: Programming and Reprogramming for Retinal Ganglion Cell Replacement Therapy

Lauren Katie Wareham, PhD; Project: Investigating the Role of the NO-GC-1-cGMP Signaling Pathway in Glaucoma

Pete A. Williams, PhD; Project: Targeting Neuronal Mitochondria for Neuroprotection in Glaucoma